Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Carcinogenesis × Monatide (IMS 3015) × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Ovarian Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Neoplasm, Residual 1 Multiple Myeloma 1 Leukemia, Myeloid, Acute 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Carcinogenesis 1

Interventions

poly ICLC 1 Poly I-C 1 Monatide (IMS 3015) 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01079741 2018-02-13

Safety Study of Adjuvant Vaccine to Treat Melanoma Patients

Icahn School of Medicine at Mount Sinai

Phase 1/2 Completed

34 enrolled 10 charts

Melanoma, Neoplasms, Skin Neoplasms, Carcinogenesis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡